Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements (Q37505185)
Jump to navigation
Jump to search
scientific article published on 12 January 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements |
scientific article published on 12 January 2012 |
Statements
1 reference
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements (English)
1 reference
D Neil Hayes
1 reference
Ezra E W Cohen
1 reference
Amy S Lucas
1 reference
Tawee Tanvetyanon
1 reference
Christine H Chung
1 reference
Barbara A Murphy
1 reference
Jill Gilbert
1 reference
Ranee Mehra
1 reference
Dominic T Moore
1 reference
Arif Sheikh
1 reference
Janelle Hoskins
1 reference
Michele C Hayward
1 reference
Ni Zhao
1 reference
Wendi O'Connor
1 reference
Roger B Cohen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference